Highly conserved tyrosine stabilizes the active state of rhodopsin
Light-induced isomerization of the 11-cis-retinal chromophore in the visual pigment rhodopsin triggers displacement of the second extracellular loop (EL2) and motion of transmembrane helices H5, H6, and H7 leading to the active intermediate metarhodopsin II (Meta II). We describe solid-state NMR mea...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 107; no. 46; pp. 19861 - 19866 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
16.11.2010
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Light-induced isomerization of the 11-cis-retinal chromophore in the visual pigment rhodopsin triggers displacement of the second extracellular loop (EL2) and motion of transmembrane helices H5, H6, and H7 leading to the active intermediate metarhodopsin II (Meta II). We describe solid-state NMR measurements of rhodopsin and Meta II that target the molecular contacts in the region of the ionic lock involving these three helices. We show that a contact between Arg135 3.50 and Met257 6.40 forms in Meta II, consistent with the outward rotation of H6 and breaking of the dark-state Glu134 3.49 -Arg135 3.50 -Glu247 6.30 ionic lock. We also show that Tyr223 5.58 and Tyr306 7.53 form molecular contacts with Met257 6.40 . Together these results reveal that the crystal structure of opsin in the region of the ionic lock reflects the active state of the receptor. We further demonstrate that Tyr223 5.58 and Ala132 3.47 in Meta II stabilize helix H5 in an active orientation. Mutation of Tyr223 5.58 to phenylalanine or mutation of Ala132 3.47 to leucine decreases the lifetime of the Meta II intermediate. Furthermore, the Y223F mutation is coupled to structural changes in EL2. In contrast, mutation of Tyr306 7.53 to phenylalanine shows only a moderate influence on the Meta II lifetime and is not coupled to EL2. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Author contributions: J.A.G., S.A., M.E., and S.O.S. designed research; J.A.G., K.S., S.A., E.Z., C.A.O., M.E., R.V., and P.J.R. performed research; E.Z., C.A.O., R.V., and P.J.R. contributed new reagents/analytic tools; J.A.G., K.S., S.A., E.Z., M.E., R.V., P.J.R., and S.O.S. analyzed data; and J.A.G., M.E., R.V., P.J.R., and S.O.S. wrote the paper. Edited by Richard Henderson, Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom, and approved September 23, 2010 (received for review June 30, 2010) |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1009405107 |